myocardial infarction

Syndicate content

Explaining origins of cardiac fibrosis in patients with heart disease

A report led by researchers at Beth Israel Deaconess Medical Center (BIDMC) helps explain the origins of cardiac fibrosis, a stiffening of the heart muscle that leads to a variety of cardiac diseases, most notably heart failure.

Get the full story...

HIV infection appears to increases risk of heart attack

Researchers from Massachusetts General Hospital (MGH) have found that infection with HIV, the virus that causes AIDS, is also associated with increased risk of myocardial infarction or heart attack. While rates of several cardiovascular risk factors were also increased in study participants infected with HIV, the increased incidence of heart attack was beyond what could be explained by risk factor differences.

Get the full story...

Studies explore lifestyle choices and heart risks

Genetics and family history play a large role in a person's risk for heart disease, but factors in diet, lifestyle and the environment are also thought to influence susceptibility to the disease.

Get the full story...

Low-dose aspirin beats high-dose after cardiac surgery

The use of medicines to fight cardiovascular disease has been a primary focus of research in this area for the past several decades, as combinations of interventions and medicinal therapy have gradually begun to increase long-term survival rates.

Get the full story...

Reduction of body iron stores and cardiovascular outcomes

The reduction of body iron stores through phlebotomy (blood removal) in patients with peripheral artery disease (PAD) does not appear to decrease the risk of death plus nonfatal cardiovascular events, according to a study published in the February 14 issue of JAMA.

Read the full story

Medication does not offer benefit for certain heart attack patients undergoing PCI

Use of the drug pexelizumab immediately before and for 24 hours after stent placement or angioplasty for certain heart attack patients did not have any significant treatment effect compared to placebo, according to a study in the January 3 issue of JAMA. The medication had shown promise in preliminary studies.

Read the full story